Stay updated on Radical-Dose IGRT in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    19 days ago
    Change Detected
    Summary
    The page shows Revision: v3.3.2 replacing v3.2.0, indicating a minor maintenance/version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-26T08:00:29.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    Removed the notice about lapse in government funding and potential updates to operating status. This does not affect the study details, eligibility criteria, or outcomes listed on the page.
    Difference
    0.4%
    Check dated 2025-11-19T08:39:24.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Results have been posted with estimated results dates (Results First Posted 2025-11-05) and related submission updates (Results First Submitted 2025-06-20), and includes enrollment (45) and study completion dates. Primary and secondary outcomes have been detailed further, including progression-free survival at 24 weeks (RECIST 1.1), overall response, overall survival, and biomarker analyses (circulating tumor DNA and immune markers) along with toxicity data.
    Difference
    3%
    Check dated 2025-11-12T00:31:26.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The Study Details page for NCT03176173 appears unchanged between the screenshots, including the eligibility criteria, study design, and locations. No new content or deletions affecting user understanding are observed.
    Difference
    0.4%
    Check dated 2025-10-28T05:24:27.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government funding notice and NIH Clinical Center operating details; removes v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-06T16:06:13.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T09:57:06.000Z thumbnail image

Stay in the know with updates to Radical-Dose IGRT in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.